Drawing for TELOID

USPTO serial 98855334

TELOID

Reviewed by CopyMark Law Group

Reg. 7888158Status 700Registered
Filing date
Status date
Registration date
Aug 12, 2025
Examiner
HOFFMAN, CHRISTOPHER J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TELOID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jong Park

Jong Park THE PL LAW GROUP, PLLC13800 Coppermine RdFL 1-3Herndon, VA 20171

Goods and services

ClassDescriptionStatusFirst use
042Research and development of vaccines and medicine; medicine research; medical and pharmacological research services; scientific research services for medical purposes in the field of oncology; development of pharmaceutical preparations and medicines; consultancy in analysis of biology sequence processing for medical research purposes; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; medical research laboratory services; scientific investigations for medical purposes; quality management services, namely, quality analysis and evaluation in the field of medical product development; drug discovery services; research on the subject of pharmaceuticals; medical research laboratory services; development of biological pharmaceutical preparations; research and development of amino acid for medical purpose; development of cell therapy products; laboratory research services relating to pharmaceuticals; scientific research for medical purposes in the field of cancerous diseases; conducting clinical studies of medicines for others; scientific research in the field of pharmacy; pharmaceutical research and development; biotechnology research; biomedical research services; pharmaceutical drug development; stem cell research services; pharmaceutical research services; consultancy in analysis of genomics for medical research purposes; basic and clinical research in the field of respiratory science and medicine; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical products evaluation; scientific research for medical purposes in the area of cancerous diseases; research and development of peptide for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 12, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 24, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 24, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 18, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 19, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2025XAECEXAMINER'S AMENDMENT ENTERED—
May 19, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 19, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
May 19, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
May 12, 2025DOCKASSIGNED TO EXAMINER—
Apr 26, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2024TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Dec 10, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 15, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance